Form 8-K - Current report:
SEC Accession No. 0001493152-25-017117
Filing Date
2025-10-06
Accepted
2025-10-06 17:25:36
Documents
12
Period of Report
2025-10-01
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 40143
  Complete submission text file 0001493152-25-017117.txt   205936

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE scnx-20251001.xsd EX-101.SCH 3041
3 XBRL LABEL FILE scnx-20251001_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE scnx-20251001_pre.xml EX-101.PRE 22376
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3684
Mailing Address 20 AUSTIN BLVD. COMMACK NY 11725
Business Address 20 AUSTIN BLVD. COMMACK NY 11725 (800) 261 0281
Scienture Holdings, Inc. (Filer) CIK: 0001382574 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39199 | Film No.: 251377713
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)